Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
PPLPHARMA Stock Analysis
Views
Red Flags
Positive
Low Debt to Equity, not much change from last year
Company's earnings are of high quality
Negative
Stock is fairly expensive with negative EPS on a trailing 12-month basis
Analysts have been downgrading forward EPS estimates
Low but stable ROE
Low and declining operating margin
Low revenue growth and lower than median growth of industry
Low EPS growth and lower than median growth of industry
Low dividend yield
Neutral
Not enough talking point with neutral stance
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
PPLPHARMA Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
PPLPHARMA Bulk, Block & Insider Trades
PPLPHARMA Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Rights issue
Rights issue(5 new shares @ 81 INR for 46 existing shares)"Rights ISIN INE0DK520011 CINS Y6985K138 SEDOL BNG4DR4." Ex-date: 2nd Aug 2023 Announced on: 28th Mar 2023
Company Profile
Piramal Pharma Limited is a global pharmaceutical company, which offers a portfolio of differentiated pharma products across a domestic and global distribution network. It operates approximately 17 development and manufacturing facilities across India, the United Kingdom/Europe, and North America. I... Read More
Key personnel
Ms. Nandini A. PiramalD
Executive Chairman of the Board
Mr. Vivek ValsarajD
Chief Financial Officer, Executive Director
Ms. Tanya Sanish
Compliance Officer, Company Secretary
Mr. Peter DeYoungD
Executive Director, Chief Executive Officer of Global Pharma
Amit JainD
Non-Executive Director
Ms. Nathalie LeitchD
Non-Executive Director
Mr. Sridhar GorthiD
Non-Executive Independent Director
Mr. Jairaj Manohar PurandareD
Non-Executive Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Piramal Pharma Ltd.?
The current share price of Piramal Pharma Ltd. is ₹ 168.57 as of 09 Jan 2026.
What is the PE ratio of Piramal Pharma Ltd.?
The Price-to-Earnings (PE) ratio of Piramal Pharma Ltd. is - as of the latest financial data.
What is the ROE and ROCE of Piramal Pharma Ltd.?
Piramal Pharma Ltd. has a Return on Equity (ROE) of -0.30% and a Return on Capital Employed (ROCE) of 2.53% as per the latest financial reports.
What is the market cap of Piramal Pharma Ltd.?
The market capitalization of Piramal Pharma Ltd. stands at ₹ 22,330.40 Cr.
What is the dividend yield of Piramal Pharma Ltd.?
The dividend yield of Piramal Pharma Ltd. is 0.08% based on the current market price.
What is the RSI of Piramal Pharma Ltd.?
The Relative Strength Index (RSI) of Piramal Pharma Ltd. is 38.56.
What is the FII and DII holding in Piramal Pharma Ltd.?
Foreign Institutional Investors (FII) hold 30.27% and Domestic Institutional Investors (DII) hold 14.60% of Piramal Pharma Ltd. shares.
What sector does Piramal Pharma Ltd. belong to?
Piramal Pharma Ltd. operates in the Healthcare sector.
What is the beta of Piramal Pharma Ltd. stock?
The beta of Piramal Pharma Ltd. stock is 1.15, indicating its volatility relative to the broader market.
